Drug firms don’t disclose enough

The editor-in-chief of the New England Journal of Medicine accused three of the largest drug companies of ‘making a mockery‘ of efforts to create transparency in clinical trials, adding that could lead some important medical publications to avoid publishing their studies.


Leave a Reply

Your email address will not be published. Required fields are marked *